Bladder Cancer Clinical Trials
Discover hundreds of clinical trials for bladder cancer.
Innovative therapies that use your immune system to attack bladder cancer.
Immunotherapy is an innovative form of treatment that trains your immune system to recognize cancer cells and destroy them like any other disease. We also can use immunotherapy to strengthen your immune system and unleash its full potential in the battle against non-invasive (superficial) and advanced bladder cancers.
Our team may recommend immunotherapy following transurethral resection (TUR) as part of your treatment plan if you’ve been diagnosed with non-invasive (superficial) bladder cancer.
First, your doctor will use the TUR procedure to scrape or burn off the cancer from the surface layers of the bladder. Next, you’ll receive an injection of immunotherapy medication into your bladder to destroy any remaining cancer cells.
We offer two forms of immunotherapy for non-invasive bladder cancer:
In addition to the intravesical immunotherapy we use for some patients with superficial bladder cancer, our doctors continue to research other forms of immunotherapies, such as antibody therapies and cancer vaccines, as potential options to treat advanced bladder cancer.
Some additional immunotherapy options include:
These drugs can be used in different situations to treat bladder cancer.
Please call 911 if you have an emergency or urgent medical question.
If you are having symptoms of COVID-19, for your safety, please select a MyChart video visit on demand or call your primary care provider. For symptoms of COVID-19, please visit our website www.henryford.com/coronavirus.
Henry Ford Health System is committed to ensuring our Deaf or hard-of-hearing patients and visitors have equal access to all services. We provide the appropriate auxiliary aids and services, including qualified sign language interpreters, TTYs and other assistive listening devices, at no cost. To request assistance, call 313-916-1896 or email [email protected].